BibTex RIS Cite

DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI

Year 2017, Volume: 11 Issue: 1, 20 - 23, 01.02.2017

Tijen Acarkan Hüseyin Nazlıkul

Abstract

Depresyon bütün dünya ülkelerinde hızla büyüyen salgın bir hastalıktır. Kinezyoloji, akupunktur, ortomoleküler yaklaşım, homeopati, biyorezonans ve çok sayıda komplementar tedavi yöntemleri depresyon tedavisine farklı bir bakış açısı sağlamaktadır. Depresyonun en sık nedenlerinin başında hormonal denge bozukluğu ve disbiyozis gelmektedir. Gerek bu iki patolojik durumda gerekse modern tıbbın uzak olduğu bozucu alan kaynaklı depresyon vakalarında nöralterapi etkin sonuçlar yaratmaktadır

Keywords

Depresyon komplementar tedavi nöralterapi

References

  • Narrow WE. One-Year Prevalence of Depressive Disorders Among Adults 18 and Over in the U.S.: NIMH ECA Prospective Data. Population estima- tes based on U.S. Census estimated residential population age 18 and over on July 1, 1998
  • Reconsidering the definition of Major Depression based on Collaborative Psychiatric Epidemiology Surveys. J Affect Disord. 2016 Sep 20;207:38- 46. doi: 10.1016/j.jad.2016.09.014. [Epub ahead of print]
  • Davidson, R.J., Irwin, W., (1999). The functional neuroanatomy of emoti- on and affective style. Trends Cog. Sci. 3 (1), 11–21.
  • LeDoux, J., (1996). The Emotional Brain: The Mysterious Underpinnings of Emotional Life. Simon and Schuster,
  • Amerikan Psikiyatri Birligi. Psikiyatride hastalıkların tanımlanması ve sı- nıflandırılması (DSM-4-TR). Köroglu E. 2. Baskı, Ankara: Hekimler Yayın Birliği, 2001, 191-209.
  • Shanghai Arch Psychiatry. 2016 Feb 25;28(1):42-7. doi: 10.11919/j. issn.1002-0829.216015.
  • Simon GE, VonKortf M, Piccinelli M, Fullerton C, Ormel J. An internatio- nal study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329-35
  • J Affect Disord. 2016 Sep 20;207:38-46.
  • Nazlıkul, H.: Nöralterapi – Nobel Tıp Kitapevi 2010
  • Weinschenk, S.: Neuraltherapie – 2010
  • Applied Kinesiology, Revised Edition APRIL 9, 2016 Robert Frost Ph.D.
  • H.Nazlıkul, Akupunktur ve Tamamlayıcı Tıp, Nobel , 2002
  • Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D incre- ases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36:193-6.
  • Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med. 1989;19(1):57-63.
  • Zirpel L, Parks TN. Zinc inhibition of group I mGluR-mediated calcium ho- meostasis in auditory neurons. J Assoc Res Otolaryngol. 2001;2:180–187.
  • http://www.naturesbounty.com/vf/healthnotes/HN77/HN77_english/ Concern/Depression.htm#Introductory
  • Gelenberg AJ, Wojcik JD, Growdon JH, et al. Tyrosine for the treatment of depression. Am J Psychiatry 2005;137:622–3.
  • Beckmann H, Athen D, Olteanu M, Zimmer R. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr 2009;227:49–58.
  • D’Elia G, Hanson L, Raotma H. L-tryptophan and 5-hydroxytryptop- han in the treatment of depression. A review. Acta Psychiatr Scand 1978;57:239–52 [review].
  • Meyers S. Use of neurotransmitter precursors for treatment of depressi- on. Altern. Med. Rev. 2000 Feb; 5(1): 64-71
  • Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: Meta- analysis of clinical studies. Acta Neurol Scand 1994;154(suppl):7–14
  • Rigaud AS, Pellerin J. Neuropsychic effects of dehydroepiandrosterone. Ann. Med. Interne 2001 Apr; 152(Suppl. 3): IS43-IS49.
  • Wolkowitz OM, Reus VI, Roberts E. et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 2010 eb 1; 41(3): 311-8.
  • Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatr Res 2011;77:57–61.
  • Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998;155:1119–21
  • Nazlikul, H.: Hayatı Keşfet – Alfa Kitabevi III. Baskı 2010 İstanbul
  • Lehrbuch Naturheilverfahren Karin Kraft, Rainer Stange Thieme, 2015

COMPLEMANTARY MEDICINE APPROACH TO DEPRESSION

Year 2017, Volume: 11 Issue: 1, 20 - 23, 01.02.2017

Tijen Acarkan Hüseyin Nazlıkul

Abstract

Depression is a rapidly growing epidemic in all countries of the world. Kinesiology, acupuncture, orthomolecular approach, homeopathy, bioresonance and a multitude of complementary therapies provide a different perspective on depression treatment. The most common causes of depression are hormonal disbalance and dysbiozis. In these two pathological conditions, neural therapy is effective in cases of disturbed area depression where modern medicine is far away

Keywords

Depression complementary therapy neural therapy

References

  • Narrow WE. One-Year Prevalence of Depressive Disorders Among Adults 18 and Over in the U.S.: NIMH ECA Prospective Data. Population estima- tes based on U.S. Census estimated residential population age 18 and over on July 1, 1998
  • Reconsidering the definition of Major Depression based on Collaborative Psychiatric Epidemiology Surveys. J Affect Disord. 2016 Sep 20;207:38- 46. doi: 10.1016/j.jad.2016.09.014. [Epub ahead of print]
  • Davidson, R.J., Irwin, W., (1999). The functional neuroanatomy of emoti- on and affective style. Trends Cog. Sci. 3 (1), 11–21.
  • LeDoux, J., (1996). The Emotional Brain: The Mysterious Underpinnings of Emotional Life. Simon and Schuster,
  • Amerikan Psikiyatri Birligi. Psikiyatride hastalıkların tanımlanması ve sı- nıflandırılması (DSM-4-TR). Köroglu E. 2. Baskı, Ankara: Hekimler Yayın Birliği, 2001, 191-209.
  • Shanghai Arch Psychiatry. 2016 Feb 25;28(1):42-7. doi: 10.11919/j. issn.1002-0829.216015.
  • Simon GE, VonKortf M, Piccinelli M, Fullerton C, Ormel J. An internatio- nal study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329-35
  • J Affect Disord. 2016 Sep 20;207:38-46.
  • Nazlıkul, H.: Nöralterapi – Nobel Tıp Kitapevi 2010
  • Weinschenk, S.: Neuraltherapie – 2010
  • Applied Kinesiology, Revised Edition APRIL 9, 2016 Robert Frost Ph.D.
  • H.Nazlıkul, Akupunktur ve Tamamlayıcı Tıp, Nobel , 2002
  • Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D incre- ases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36:193-6.
  • Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med. 1989;19(1):57-63.
  • Zirpel L, Parks TN. Zinc inhibition of group I mGluR-mediated calcium ho- meostasis in auditory neurons. J Assoc Res Otolaryngol. 2001;2:180–187.
  • http://www.naturesbounty.com/vf/healthnotes/HN77/HN77_english/ Concern/Depression.htm#Introductory
  • Gelenberg AJ, Wojcik JD, Growdon JH, et al. Tyrosine for the treatment of depression. Am J Psychiatry 2005;137:622–3.
  • Beckmann H, Athen D, Olteanu M, Zimmer R. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr 2009;227:49–58.
  • D’Elia G, Hanson L, Raotma H. L-tryptophan and 5-hydroxytryptop- han in the treatment of depression. A review. Acta Psychiatr Scand 1978;57:239–52 [review].
  • Meyers S. Use of neurotransmitter precursors for treatment of depressi- on. Altern. Med. Rev. 2000 Feb; 5(1): 64-71
  • Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: Meta- analysis of clinical studies. Acta Neurol Scand 1994;154(suppl):7–14
  • Rigaud AS, Pellerin J. Neuropsychic effects of dehydroepiandrosterone. Ann. Med. Interne 2001 Apr; 152(Suppl. 3): IS43-IS49.
  • Wolkowitz OM, Reus VI, Roberts E. et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 2010 eb 1; 41(3): 311-8.
  • Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatr Res 2011;77:57–61.
  • Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998;155:1119–21
  • Nazlikul, H.: Hayatı Keşfet – Alfa Kitabevi III. Baskı 2010 İstanbul
  • Lehrbuch Naturheilverfahren Karin Kraft, Rainer Stange Thieme, 2015
There are 27 citations in total.

Details

Other ID JA23RK36FS
Journal Section Research
Authors

Tijen Acarkan This is me

Hüseyin Nazlıkul This is me

Publication Date February 1, 2017
Published in Issue Year 2017 Volume: 11 Issue: 1

Cite

APA Acarkan, T., & Nazlıkul, H. (2017). DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI. Bilimsel Tamamlayıcı Tıp Regülasyon Ve Nöral Terapi Dergisi, 11(1), 20-23.
AMA Acarkan T, Nazlıkul H. DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI. BARNAT. February 2017;11(1):20-23.
Chicago Acarkan, Tijen, and Hüseyin Nazlıkul. “DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI”. Bilimsel Tamamlayıcı Tıp Regülasyon Ve Nöral Terapi Dergisi 11, no. 1 (February 2017): 20-23.
EndNote Acarkan T, Nazlıkul H (February 1, 2017) DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI. Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi 11 1 20–23.
IEEE T. Acarkan and H. Nazlıkul, “DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI”, BARNAT, vol. 11, no. 1, pp. 20–23, 2017.
ISNAD Acarkan, Tijen - Nazlıkul, Hüseyin. “DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI”. Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi 11/1 (February 2017), 20-23.
JAMA Acarkan T, Nazlıkul H. DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI. BARNAT. 2017;11:20–23.
MLA Acarkan, Tijen and Hüseyin Nazlıkul. “DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI”. Bilimsel Tamamlayıcı Tıp Regülasyon Ve Nöral Terapi Dergisi, vol. 11, no. 1, 2017, pp. 20-23.
Vancouver Acarkan T, Nazlıkul H. DEPRESYONA TAMAMLAYICI TIP YAKLAŞIMI. BARNAT. 2017;11(1):20-3.